Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label study to evaluate the efficacy and safety of a daily single
oral dose of tasimelteon in treating sleep disturbances in pediatric and adult participants
with ASD.